1.Elfarra AA, Hanna PE.. (1985) Substituent effects on the bioactivation of 2-(N-hydroxyacetamido)fluorenes by N-arylhydroxamic acid N,O-acyltransferase., 28 (10):[PMID:4045921][10.1021/jm00148a014]
2.Banks RB, Smith TJ, Hanna PE.. (1983) N-arylhydroxamic acid N,O-acyltransferase. Positional requirements for the substrate hydroxyl group., 26 (12):[PMID:6644748][10.1021/jm00366a026]
3.Marhevka VC, Ebner NA, Sehon RD, Hanna PE.. (1985) Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes., 28 (1):[PMID:3965709][10.1021/jm00379a005]
4.Yuta K, Jurs PC.. (1981) Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines., 24 (3):[PMID:7265110][10.1021/jm00135a003]
5.Yeh H, Hanna PE.. (1982) Arylhydroxamic acid bioactivation via acyl group transfer. Structural requirements for transacylating and electrophile-generating activity of N-(2-fluorenyl)hydroxamic acids and related compounds., 25 (7):[PMID:7108899][10.1021/jm00349a015]
6. (2008) Casarett and Doull's Toxicology The Basic Science of Poisons, 7th edition,
7.Tukey RH, Strassburg CP.. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease., 40 (1):[PMID:10836148][10.1146/annurev.pharmtox.40.1.581]
8.Burt RK, Thorgeirsson SS.. (1988) Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics., 80 (1):[PMID:2845109][10.1093/jnci/80.17.1383]